Pulmonary malakoplakia is a disease that is difficult to diagnose because its symptoms vary from those mimicking bronchogenic carcinoma to pneumonitis-like tuberculous infections. Malakoplakia is an unusual inflammatory condition characterized by the accumulation of macrophages with diagnostic Michaelis-Gutmann bodies. In this study, an immunocompromised patient with a tumor mass in the upper lobe of the right lung coexisting with hilar node enlargement is presented. A thoracoscopic biopsy revealed pulmonary malakoplakia with tuberculosis of the hilar lymph node. Microbiologic cultures were positive for acid-fast positive bacilli from the hilar node specimen, and negative for any other microorganisms such as Rhodococcus equi, but positive for Escherichia coli from the lung specimen. The significance of these findings and the coincidental association between malakoplakia and tuberculosis are discussed.

Crouch E, White V, Wright J, et al: Malakoplakia mimicking carcinoma metastatic to lung. Am J Surg Pathol 1984;8:151–156.
Miranda D, Vuletin JC, Kaufman SL: Disseminated histiocytosis and intestinal malakoplakia: Occurrence due to Mycobacterium intracellulare infection. Arch Pathol Lab Med 1979;103:448–450.
Lou TY, Teplitz C: Malakoplakia: Pathogenesis and ultrastructural morphogenesis: A problem of altered macrophage (phagolysosomal) response. Hum Pathol 1974;5:191–207.
Byard RW, Bourne AJ, Thorner PS: Malakoplakia of the lung – A review. Surg Pathol 1991;4:301–308.
Colby TV, Hunt S, Pelzmann K, et al: Malakoplakia of the lung: A report of two cases. Respiration 1980;39:295–299.
Hodder RV, St George-Hyslop P, Chalvardjian A, Bear RA, Thomas P: Pulmonary malakoplakia. Thorax 1984;39:70–71.
Scannell KA, Portoni EJ, Finkle HI, et al: Pulmonary malakoplakia and Rhodococcus equi infection in a patient with AIDS. Chest 1990;97:1000–1001.
Kwon KY, Colby TV: Rhodococcus equi pneumonia and pulmonary malakoplakia in acquired immunodeficiency syndrome. Pathologic features. Arch Pathol Lab Med 1994;118:744–748.
Schwartz DA, Ogden PO, Blumberg HM, et al: Pulmonary malakoplakia in a patient with AIDS: Differential diagnostic consideration. Arch Pathol Lab Med 1990;114:1267–1272.
de Peralta-Venturina MN, Clubb FJ, Kielhofner MA: Pulmonary malakoplakia associated with Rhodococcus equi infection in a patient with AIDS. Am J Clin Pathol 1994;102:459–463.
Guerrero MF, Ramos JM, Renedo G, et al: Pulmomary malakoplakia associated with Rhodococcus equi infection in patients with AIDS: Case report and review. Clin Infect Dis 1999;28:1334–1336.
Bastas A, Markou N, Botsi C, et al: Malakoplakia of the lung caused by Pasteurella multocida in a patient with AIDS. Scand J Infect Dis 2002;34:536–538.
Lambert C, Gansler T, Mansour KA, et al: Pulmonary malakoplakia diagnosed by fine needle aspiration: A case report. Acta Cytol 1997;4:1833–1838.
Yuoh G, Hove MG, Wen J, et al: Pulmonary malakoplakia in AIDS: An ultrastructural study of morphogenesis of Michaelis-Gutmann bodies. Mod Pathol 1996;9:476–483.
Shin MS, Cooper JAD, Ho KJ: Pulmonary malakoplakia associated with Rhodococcus equi infection in a patient with AIDS. Chest 1999;115:889–892.
Hoeven KH, Dookhan DB, Petersen RO: Cytologic features of pulmonary malakoplakia related to Rhodococcus equi in an immunocompromised host. Diagn Cytopathol 1996;15:325–328.
Stanton MJ, Maxted W: Malakoplakia: A study of the literature and current concepts of pathogenesis, diagnosis and treatment. J Urol 1981;125:139–146.
Gupta R, Schuster R, Christian W: Autopsy finding in a unique case of malakoplakia. Arch Pathol 1972;93:42–48.
Govender D, Essa AS: Malakoplakia and tuberculosis. Pathology 1999;31:280–283.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.